SCHEMBL467535

SCHEMBL467535

O=c1[nH]c(CCCC2CC(c3ccccc3)=CCN2)nc2cccc(Cl)c12

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 17/20 0.60
PARP2 Q9UGN5 2/20 0.52
PDE10A Q9Y233 1/20 0.45
PBRM1 Q86U86 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7018458 0.85 PARP1 (0.55) PARP1PARP2PDE10A
SCHEMBL7017660 0.85 PARP1 (0.60) PARP1PARP2
SCHEMBL7014565 0.80 PARP1 (0.59) PARP1PARP2PDE10A
SCHEMBL7021104 0.78 PARP1 (0.48) PARP1PARP2PDE10A
SCHEMBL7023192 0.78 PARP1 (0.49) PARP1PARP2
SCHEMBL6648890 0.77 PARP1 (0.56) PARP1
SCHEMBL6646707 0.77 PARP1 (0.58) PARP1
SCHEMBL7017894 0.77 PARP1 (0.48) PARP1PARP2
SCHEMBL7017391 0.77 PARP1 (0.47) PARP1PARP2
Hydrochloric Acid SCHEMBL7019654 0.77 PARP1 (0.51) PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014152330-A1 ARSENIC-BASED TREATMENT OF CANCERS AND INFLAMMATORY DISORDERS STC.UNM (US) 2014-09-25 WO claimed
EP-2387403-A1 METHOD OF TREATING CANCER Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL) 2011-11-23 EP claimed
US-20110253692-A1 Electrical heater for vehicle windshields and windows SCHAUBLE RICHARD EGON 2011-10-20 US claimed
WO-2010082821-A1 METHOD OF TREATING CANCER ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) 2010-07-22 WO claimed
WO-2010082813-A1 METHOD OF TREATING CANCER ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) 2010-07-22 WO claimed
WO-2009114459-A2 ANTI-NEOPLASTIC COMBINATION THERAPEUTIC REGIMEN INVOLVING CO-DISRUPTION OF PARP PATHWAY AND MRE11/RAD50/NBS1 COMPLEX AND COMPOSITONS USEFUL THEREIN THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-09-17 WO claimed
EP-1962843-A4 USE OF PARP-1 INHIBITORS PHARMA MAR SA (ES) 2009-08-12 EP claimed
EP-1962843-A2 USE OF PARP-1 INHIBITORS University of Medicine and Dentistry New Jersey (US) 2008-09-03 EP claimed
WO-2007062413-A2 USE OF PARP-1 INHIBITORS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2007-05-31 WO claimed
WO-2013121042-A1 PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER VIB VZW (BE) 2013-08-22 WO disclosed
EP-2389589-A2 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS Brigham and Women's Hospital, Inc. (US) 2011-11-30 EP disclosed
EP-2387403-A1 METHOD OF TREATING CANCER Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL) 2011-11-23 EP disclosed
US-20110253692-A1 Electrical heater for vehicle windshields and windows SCHAUBLE RICHARD EGON 2011-10-20 US disclosed
WO-2010090859-A2 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2010-08-12 WO disclosed
EP-1962843-A4 USE OF PARP-1 INHIBITORS PHARMA MAR SA (ES) 2009-08-12 EP disclosed
EP-1962843-A2 USE OF PARP-1 INHIBITORS University of Medicine and Dentistry New Jersey (US) 2008-09-03 EP disclosed
WO-2008016707-A2 USE OF IL-6 IN THE DIAGNOSIS AND TREATMENT OF NEUROINFLAMMATORY CONDITIONS THE JOHNS HOPKINS UNIVERSITY (US) 2008-02-07 WO disclosed
WO-2007062413-A2 USE OF PARP-1 INHIBITORS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2007-05-31 WO disclosed
EP-1355888-A1 QUINAZOLINONE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-10-29 EP disclosed
WO-2002048117-A1 QUINAZOLINONE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-20 WO disclosed